← Back to Stock Screener← Stock Screener

ZYBERNO

Stock Report

Updated Aug 29, 2026

VIATRIS INC. (VTRS)

Healthcare • NASDAQ

$16.61

Viatris Inc. is an American pharmaceutical company headquartered in Canonsburg, Pennsylvania, formed through the 2020 combination of Mylan and Pfizer's Upjohn division. The company markets branded and generic pharmaceuticals, complex generics, and biosimilars across approximately 165 countries, with a portfolio of approximately 1,400 approved molecules across therapeutic areas including respiratory, infectious diseases, cardiovascular, and oncology.

Professional Investment Analysis

ZYBERNO SCORE →

Is it a great business? Is it getting better?

17.0/100

POOR BUSINESS

VIATRIS INC. (VTRS) scores 17/100 — concerning metrics indicating significant structural or financial risks.

📊 How is the Zyberno Score calculated? +

The Zyberno Score answers one question: "Is this a quality business worth owning?" It's a 0-100 investment grade that evaluates business fundamentals across four critical dimensions, based on principles from Warren Buffett, Benjamin Graham, Peter Lynch, and Charlie Munger.

The 4 Core Categories (25 points each):

1. PROFITABILITY (25 pts)

Metrics: ROE, ROIC, Net Margin, Operating Margin
Thresholds: ROE >20% excellent • ROIC >20% excellent • Net Margin >20% excellent • Operating Margin >25% excellent

2. FINANCIAL STRENGTH (25 pts)

Metrics: Debt-to-Equity, Current Ratio, Interest Coverage, Altman Z-Score
Thresholds: D/E <0.3 excellent • Current Ratio >2.5 excellent • Interest Coverage >10x excellent • Altman Z >3.0 safe

3. CASH FLOW QUALITY (25 pts)

Metrics: Free Cash Flow, OCF vs Net Income, FCF Margin
Thresholds: Positive & growing FCF excellent • OCF/NI >1.2x excellent (cash earnings exceed accounting)

4. GROWTH & CONSISTENCY (25 pts)

Metrics: Revenue Growth, Net Income Growth, FCF Growth, Piotroski F-Score
Thresholds: Growth via log-linear regression • Piotroski 8-9 excellent, 6-7 good

Score Interpretation:

75-100

GREAT BUSINESS

65-74

GOOD BUSINESS

50-64

AVERAGE BUSINESS

30-49

WEAK BUSINESS

0-29

POOR BUSINESS

→ View full VTRS quality analysis & detailed breakdown

VALUATION SIGNAL

MARGIN OF SAFETY

Is this stock cheap or expensive relative to what the business has historically generated for owners?

-98.7%

Overvalued

Growth gap unavailable — insufficient data for reverse DCF calculation.

🎯 Expected Annual Return →

-26.9%

Margin of Safety convergence — your return if the market re-prices to intrinsic value (5-yr annualised)

0.2%

Yield + growth — what the business alone earns you, even if the market never re-rates

💰 How is Margin of Safety calculated? +

Margin of Safety measures how much discount or premium you're paying relative to a stock's intrinsic value. It's Benjamin Graham's core principle: the larger the margin, the lower your downside risk.

Formula: (Intrinsic Value − Current Price) ÷ Intrinsic Value × 100%

How We Calculate Intrinsic Value (DCF Method):

Step 1: Calculate current Owner Earnings (OCF − Maintenance CapEx)

Step 2: Calculate company-specific growth rate using log-linear regression on 16 quarters of Owner Earnings

Step 3: Project 10 years forward using the calculated growth rate

Step 4: Discount each year's cash flow to present value using 10% discount rate

Step 5: Calculate terminal value using 3% perpetual growth rate

Step 6: Sum all discounted cash flows = Intrinsic Value

What The Percentages Mean:

+50% or more

EXCELLENT — Very undervalued

+25% to +50%

GOOD — Attractive discount

0% to +25%

FAIR — Reasonable value

0% to -25%

CAUTION — Slight premium

-25% or worse

POOR — Overvalued

"Price is what you pay, value is what you get." — Warren Buffett

→ View full VTRS valuation analysis · → View full VTRS Brina Gap analysis

📈 How is Brina Gap calculated? +

Brina Gap measures the difference between the growth a business can fundamentally sustain and the growth the market is already pricing in.

Formula: Fundamental Growth Rate − Market-Implied Growth Rate

The Two Components:

Fundamental Growth Rate = ROIC × Reinvestment Rate

What the business can sustainably grow at based on how much it reinvests and what return it earns on that capital. Grounded in historical financials.

Market-Implied Growth Rate = Reverse DCF

The growth rate the current Enterprise Value implicitly assumes. Calculated by back-solving a 10-year DCF model (10% WACC, 3% terminal growth) until the present value of projected cash flows equals EV.

What The Gap Means:

Gap > +5% Market Underestimates — potential upside

+2% to +5% Slight Underestimate

-2% to +2% Fairly Priced — market consensus matches fundamentals

-5% to -2% Slight Overestimate

Gap < -5% Market Overestimates — price embeds optimism fundamentals don't support

A positive gap (market underestimates) combined with a positive Margin of Safety is the strongest combined signal — the business is both cheap historically and forward economics are stronger than the price suggests.

Critical Financial Health Indicators

Return on Equity (Profitability):CRITICAL (-2.8%)

Debt-to-Equity (Solvency Risk):AVERAGE (0.92x)

Operating Margin (Operational Efficiency):CRITICAL (-0.6%)

Return on Capital (Capital Efficiency):CRITICAL (-0.2%)

📊 Valuation Trilogy

Three interconnected metrics for complete valuation analysis

Click any metric for full methodology and detailed analysis

Zyberno's Verdict

VIATRIS INC. (VTRS) stock report — Zyberno Score 17/100 (POOR BUSINESS), Margin of Safety -98.7%, -27% expected annual return. Full financial analysis on Zyberno.

According to Zyberno's DCF model, VIATRIS INC. (VTRS) trades at $16.61 against an estimated intrinsic value per share of $8.36 — a -98.7% Margin of Safety based on Owner Earnings of $1.79B TTM, projected at -16.1% growth for 10 years with a 2.5% terminal growth rate. Zyberno's model translates this into a 5-year expected return of -26.9% annually.

Over the trailing twelve months, VTRS generated $1.79B in Owner Earnings. Capital was deployed as follows: $726.00M paid as dividends, $376.10M invested in capital expenditures. Reinvestment rate: 3,699.1%. Owner Earnings have declined at 16.1% annually over the trailing five years using log-linear regression.

DIVISION I: EXECUTIVE SUMMARY

A. Market Valuation

Market Price & Capitalization (2)

Current Price:16.61

Market Cap:$19.32B

Valuation Multiples (3)

P/B Ratio:1.35x

P/S Ratio:1.31x

Peg Ratio:-999.00x

Enterprise Metrics (3)

Enterprise Value:$31.79B

Ev Ebitda Ratio:7.25x

Pfcf Ratio:10.78x

Price Action & Momentum (3)

12-1 Momentum:

+105.0% (90th pctile)

📈 Click to view full VTRS Momentum analysis →

Momentum Percentile:90 / 100

% of 52-Week High:90.3%

B. Profitability Assessment

Return Metrics (5)

ROE:

-2.8%

📊 Click to view full VTRS ROE analysis →

ROA:-1.1%

Roic:

-0.2%

📊 Click to view full VTRS ROIC analysis →

Reinvestment Rate:3,699.1%

Fundamental Growth Rate (g):-9.1%

Margin Analysis (3)

Operating Margin Ttm:-0.6%

Net Margin Ttm:-2.8%

Ebitda Margin:29.8%

TTM Performance (3)

Gross Margin Ttm:34.8%

Operating Margin Ttm:-0.6%

Net Margin Ttm:-2.8%

Yield Metrics (3)

Earnings Yield:-$2.41

Owner Earnings Yield:$9.28

Dividend Yield:3.8%

C. Log-Linear Regression Growth Trends

Earnings Surprise (SUE) (3)

Earnings Surprise (SUE):

-0.07

📊 Click to view full VTRS Earnings Surprise analysis →

EPS Surprise vs Expected:-263.6%

Latest Earnings Filed:2026-08-06

Revenue Growth (Linear) (1)

Revenue Growth Rate (Linear):-2.7%

Earnings Growth (Linear) (1)

Net Income Growth Rate (Linear):-24.7%

Cash Flow Growth (Linear) (2)

Free Cash Flow Growth Rate (Linear):-16.1%

Operating Cash Flow Growth Rate (Linear):-4.7%

Operating Growth (Linear) (1)

Operating Income Growth Rate (Linear):-50.0%

D. Financial Stability

Liquidity Ratios (3)

Current Ratio:1.58x

Quick Ratio:0.96x

Cash Ratio:0.14x

Leverage Analysis (3)

Debt To Equity Ttm:0.92x

Debt-to-Equity Ratio:0.92x

Debt To Ebitda:3.04x

Coverage Ratios (2)

Interest Coverage Ratio:-5.55x

Times Interest Earned:-5.55

Capital Structure (4)

Working Capital:3,709,900,000.00

Cash And Cash Equivalents:886,500,000.00

Long Term Debt:$11.61B

Net Debt:$12.46B

DIVISION II: FINANCIAL STATEMENTS ANALYSIS

A. Income Statement Analysis

Revenue Components (2)

Revenue TTM: $14.74B

Linear Growth: -2.7%

📊 Click to view full VTRS Revenue analysis & methodology →

Cost Of Revenue Ttm:$9.60B

Profitability Breakdown (2)

Gross profit TTM: $5.13B

Linear Growth: -7.1%

📊 Click to view full VTRS Gross Profit analysis & methodology →

Operating income TTM: -$87.30M

Linear Growth: -50.0%

📊 Click to view full VTRS Operating Income analysis & methodology →

Bottom Line Performance (3)

Net income TTM: -$410.70M

Linear Growth: -24.7%

📊 Click to view full VTRS Net Income analysis & methodology →

Income Before Tax:-$662.20M

Ebitda Ttm:4,387,000,000.00

Operating Expenses (5)

Operating Expenses:5,220,400,000.00

R And D Expense:1,022,000,000.00

Sga Expense:3,980,600,000.00

Income Tax Expense:-$251.50M

Interest Expense:480,000,000.00

Expense Ratios (3)

R And D To Revenue Percentage:27.2%

Sga To Revenue Percentage:106.0%

Ebitda Margin:29.8%

B. Balance Sheet Analysis

Asset Composition (5)

Total Assets:$35.04B

Current Assets:$10.06B

Ppe Net:2,439,700,000.00

Goodwill:6,654,400,000.00

Intangible Assets:$13.68B

Liability Structure (4)

Total Liabilities:20,784,200,000.00

Current Liabilities:6,345,800,000.00

Long Term Debt:$11.61B

Short Term Debt:$1.74B

Equity & Capital (3)

Equity:$14.26B

Retained Earnings:-$330.70M

Common Stock:3,000,000,000.00

Working Capital Items (3)

Accounts Receivable:3,126,200,000.00

Inventory:3,933,200,000.00

Accounts Payable:0.00

Special Items (2)

Contract Liabilities:0.00

Stock Based Compensation:48,200,000.00

C. Cash Flow Analysis

Operating Activities (2)

Operating cash flow TTM: $2.17B

Linear Growth: -4.7%

Free cash flow TTM: $1.79B

Linear Growth: -16.1%

📊 Click to view full VTRS Free Cash Flow analysis & methodology →

Investment Activities (2)

Investing Cash Flow:$277.40M

Capital Expenditures Ttm:376,100,000.00

Financing Activities (3)

Financing Cash Flow:-$203.80M

Dividends Paid Ttm:726,000,000.00

Stock Repurchase:0.00

Capital Transactions (3)

Common Stock Issuance:500,000.00

Long Term Debt Issuance:$300.00K

Long Term Debt Repayments:$3.71B

Non-Cash Items (1)

Depreciation Amortization Ttm:4,474,300,000.00

DIVISION III: OPERATIONAL METRICS

A. Per Share Analysis

Earnings Per Share (3)

EPS (Basic TTM):-0.40

Eps diluted TTM: -$0.40

Linear Growth: -31.9%

📊 Click to view full VTRS EPS analysis & methodology →

Earnings Per Share Ttm:-$0.35

Revenue & Cash Per Share (3)

Sales Per Share Ttm:12.67

Operating Cash Flow Per Share:$1.99

Fcf Per Share Ttm:1.54

Book Value & Capital (2)

Book Value Per Share:$12.26

Cash Per Share:0.76

Dividend Policy (1)

Dividend Payout Ratio:-999.00x

B. Operational Efficiency

Asset Utilization (2)

Asset Turnover Ttm:0.40x

Working Capital Turnover Ttm:3.97x

Receivables Management (2)

Receivables Turnover Ttm:4.71x

Days Sales Outstanding Ttm:77.43

Inventory Management (2)

Inventory Turnover Ttm:2.44x

Days Inventory Outstanding Ttm:149.48

Payables & Cash Cycle (2)

Days Payable Outstanding:-999.00

Cash Conversion Cycle:1,225.91

C. Quality & Risk Metrics

Financial Quality Scores (2)

Financial Strength Score:40.00

Quality Score:40.00

Market Metrics (2)

Beta:0.00x

Volatility Category:unknown

DIVISION IV: INVESTMENT ANALYSIS

A. Value Investment Framework

Owner Earnings Analysis (3)

Owner earnings TTM: $1.79B

Linear Growth: -16.1%

📊 Click to view full VTRS Owner Earnings analysis & methodology →

Owner Earnings Per Share:$1.54

Owner Earnings Yield:$9.28

Growth Assessment (1)

Owner Earnings Growth Rate:-$16.12

Damodaran Growth Analysis (2)

Reinvestment Rate:3,699.1%

Fundamental Growth Rate (g):-9.1%

Intrinsic Value Models (1)

Intrinsic Value:

$9.72B

📊 Click to view full VTRS DCF valuation →

Margin of Safety (1)

Margin Of Safety:

-98.7%

📊 Click to view full VTRS valuation analysis →

Return Scenarios (2)

Theoretical 5-Year Return:

-26.9%

📊 Click to view full VTRS expected return analysis →

Forward Expected Return (Yield + Growth):

0.2%

📊 Click to view full VTRS expected return analysis →

Investment Assessment (1)

Buffett Assessment:Overvalued

B. Log-Linear Regression Growth Analysis

Growth Rates (Log-Linear Regression) (3)

Revenue Growth Rate (Linear):-2.7%

Net Income Growth Rate (Linear):-24.7%

Operating Income Growth Rate (Linear):-50.0%

Cash Flow Growth Rates (2)

Free Cash Flow Growth Rate (Linear):-16.1%

Operating Cash Flow Growth Rate (Linear):-4.7%

Other Growth Rates (3)

Gross Profit Growth Rate (Linear):-7.1%

Book Value Growth Rate (Linear):-8.9%

Owner Earnings Growth Rate:-$16.12

C. Company Profile & Context

Corporate Information (6)

Symbol:VTRS

Company Name:VIATRIS INC.

Sector:Healthcare

Industry:Pharmaceuticals

Exchange:NASDAQ

Country:United States

Market Classification (3)

Market Cap Category:N/A

Price Category:medium

Volume Category:N/A

Share Structure (3)

Shares Outstanding:1.16B

Shares Outstanding Basic:1.16B

Shares Outstanding Diluted:1.16B

Data Processing Info (3)

Processing Version:v3.0

Last Updated:2026-08-29 02:29:39 UTC

Data Timestamp:2026-08-29T02:29:39.874231